Corinne Nabet

Suggest Changes
Learn More
Immunological parameters were evaluated in patients treated with cytokine-mediated immunotherapy (CMI) consisting of low doses of recombinant human interferon α2a (rIFNα) and recombinant human(More)
  • 1